Kyto Technology & Life Science, Inc.
company.status.inactiveCIK 1164888fmd_1GXZ86BTBKFN2WRDNNXX0GPGFMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2017 to Dec 31, 2021, 19 periods
Latest annual · FY2020
Millions- Total revenues
- 0
- Gross profit
- (1)
- Operating income
- (2)
- Net income
- 0
- Free cash flow
- (3)
Latest quarter · Q3 FY2022
Millions- Gross profit
- (0)
- Operating income
- (1)
- Net income
- 0
Kyto Technology & Life Science, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Gross profit | -$768,842 | -$712,353 | 10-K/A 2021-08-12 · proof | |
| Operating income | -$1.5 million | -$773,399 | 10-K/A 2021-08-12 · proof | |
| Net income | $427,066 | -$773,399 | 10-K/A 2021-08-12 · proof | |
| Cash from operating activities | -$2.5 million | -$1.9 million | 10-K/A 2021-08-12 · proof | |
| Total assets | $8.4 million | $2.7 million | +212.2% | 10-K/A 2021-08-12 · proof |
| Total liabilities | $1.4 million | $32,144 | +4,367.4% | 10-Q/A 2021-10-06 · proof |
| Cash and cash equivalents | $1.4 million | $33,756 | +4,159.6% | 10-K/A 2021-08-12 · proof |
- What was Kyto Technology & Life Science, Inc.'s gross profit in fiscal 2021?
- Kyto Technology & Life Science, Inc. reported gross profit of -$768,842 for fiscal 2021 (the year ended Mar 31, 2021), against -$712,353 the year before. Source: the 10-K/A filed with the SEC on Aug 12, 2021. SEC
- What was Kyto Technology & Life Science, Inc.'s operating income in fiscal 2021?
- Kyto Technology & Life Science, Inc. reported operating income of -$1.5 million for fiscal 2021 (the year ended Mar 31, 2021), against -$773,399 the year before. Source: the 10-K/A filed with the SEC on Aug 12, 2021. SEC
- What was Kyto Technology & Life Science, Inc.'s net income in fiscal 2021?
- Kyto Technology & Life Science, Inc. reported net income of $427,066 for fiscal 2021 (the year ended Mar 31, 2021), against -$773,399 the year before. Source: the 10-K/A filed with the SEC on Aug 12, 2021. SEC
- What was Kyto Technology & Life Science, Inc.'s cash from operating activities in fiscal 2021?
- Kyto Technology & Life Science, Inc. reported cash from operating activities of -$2.5 million for fiscal 2021 (the year ended Mar 31, 2021), against -$1.9 million the year before. Source: the 10-K/A filed with the SEC on Aug 12, 2021. SEC
- What are Kyto Technology & Life Science, Inc.'s total assets?
- As of Mar 31, 2021, Kyto Technology & Life Science, Inc. reported total assets of $8.4 million, against $2.7 million a year earlier (+212.2%). Source: the 10-K/A filed with the SEC on Aug 12, 2021. SEC
- What are Kyto Technology & Life Science, Inc.'s total liabilities?
- As of Mar 31, 2021, Kyto Technology & Life Science, Inc. reported total liabilities of $1.4 million, against $32,144 a year earlier (+4,367.4%). Source: the 10-Q/A filed with the SEC on Oct 6, 2021. SEC
- What are Kyto Technology & Life Science, Inc.'s cash and cash equivalents?
- As of Mar 31, 2021, Kyto Technology & Life Science, Inc. reported cash and cash equivalents of $1.4 million, against $33,756 a year earlier (+4,159.6%). Source: the 10-K/A filed with the SEC on Aug 12, 2021. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1164888&period_type=annual&limit=5"Information only, not investment advice.